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Abstract. 
 Hutchinson-Gilford Progeria Syndrome is a rare genetic disorder that 
mimics certain aspects of aging prematurely. Recent work has revealed that 
mutations in the lamin A gene are a cause of the disease. We show here that 
cellular aging of Hutchinson-Gilford progeria syndrome fibroblasts is 
characterised by a period of hyperproliferation and terminates with a large 
increase in the rate of apoptosis. The occurrence of cells with abnormal nuclear 
morphology reported by others is shown to be a result of cell division since the 
fraction of these abnormalities increases with cellular age. Similarly, the 
proportion of cells with an abnormal or absent A-type lamina increases with age. 
These data provide clues as to the cellular basis for premature aging in HGPS 
and support the view that cellular senescence and tissue homeostasis are 
important factors in the normal aging process. 
 1. Introduction. 
Hutchinson-Gilford progeria syndrome (HGPS) is a rare genetic disorder that 
is characterized by aspects of accelerated and premature aging (Brown, 1992). 
Individuals affected with HGPS appear normal at birth but typically show growth 
defects within a year. Growth continues at a slow rate and by the second year there is 
usually a loss of scalp hair, eyelashes and eyebrows and lipodystrophy (redistribution 
of body fat, in particular, a marked reduction in subcutaneous fat). As the disorder 
develops, individuals suffer from stiffened joints and experience mild to severe 
limitation to motion. Death occurs at a mean age of 13.4 years usually from heart 
attacks or congestive heart failure (DeBusk, 1972). Widespread atherosclerosis is 
usually seen upon autopsy (Baker et al., 1981). Cytogenetic studies have led to 
chromosome 1 as the most likely candidate chromosome to carry the HGPS gene 
(Delgado Luengo et al., 2002) and recently it has been shown that HGPS is caused by 
mutations in the lamin A gene (Cao and Hegele, 2003; De Sandre-Giovannoli et al., 
2003; Eriksson et al., 2003), which is present on HSA1. This places HGPS within a 
class of syndromes termed the “laminopathies” (Gruenbaum et al., 2003) and includes 
Autosomal Emery-Dreifuss Muscular Dystrophy (Bonne et al., 1999), Dunnigan-type 
familial partial lipodystrophy (Cao and Hegele, 2000), autosomal dominant limb-
girdle muscular dystrophy 1B (Muchir et al., 2000) and autosomal recessive axonal 
neuropathy (Charcot-Marie-Tooth type 2 disease 2B1) (De Sandre-Giovannoli et al., 
2002).  
Lamin A belongs to a family of nuclear intermediate-type filament proteins 
that form an insoluble network of filaments beneath the inner nuclear membrane. 
However, lamins have also been localised to the nuclear interior in speckles (Bridger 
et al., 1993) and as part of the interior nuclear matrix (Barboro et al., 2002; Hozak et 
al., 1995). A-type lamins have also been found in association with transcription 
factors (Dreuillet et al., 2002; Lloyd et al., 2002). Furthermore, disruption of  normal 
lamin organization by microinjection of a dominant-negative lamin A mutant results 
in inhibition of both DNA replication (Spann et al., 1997) and RNA polymerase II-
dependent transcription (Spann et al., 2002) suggesting a role for lamin A in both 
these processes. Finally, lamins have the ablilty to bind dirctly to DNA (Stierle et al., 
2003) and to chromatin (Glass et al., 1993; Taniura et al., 1995) and indirectly via 
associations with proteins containing a LEM box (Lee et al., 2001; Martins et al., 
2003). Thus, the list of possible functions of the A-type lamins includes maintenance 
of nuclear structural integrity, organisation of higher-order chromatin structure and 
control of gene expression (Hutchison, 2002). Nevertheless, it is an important finding 
that mutations in the lamin A gene can give rise to a range of diseases and in 
particular to premature aging. Therefore it is essential to understand how lamin A 
mutations affect cell function and in the case of HGPS, how the mutations result in 
premature aging. In this study we have compared the rates of cellular aging and 
apoptosis in normal and HGPS fibroblast cultures. In addition, we have compared 
nuclear morphology and nuclear lamina organisation in young and senescent HGPS 
fibroblasts. 
2. Materials and Methods. 
 
2.1 Cell culture 
 
Normal dermal fibroblast cultures 1BR (Arlett et al., 1975), 2DD (Bridger et al., 
1993) and NB1 (Bolland, 2003) have been described previously. HGPS fibroblasts 
were obtained from the Coriell Cell Repository (see Table 1.). Cells were grown in 
DMEM containing 15% fetal bovine serum at 37oC in 5% CO2/95% air. Cultures 
were passaged twice weekly and seeded at 2x105 per 90mm diameter dish. Cell 
growth was measured by calculation of accumulated population doublings using the 
formula (logH – logS)/log2.0 where logH is the logarithm of the number of cells 
harvested after 3 or 4 days growth and logS is the logarithm of the number of cells 
seeded on the first day of each passage.  
 
2.2 Indirect immunofluorescence 
 
Cells grown on coverslips were washed in PBS then fixed with 4% parafomaldehyde 
in PBS for 10 minutes at room temperature. Fixed cells were washed with PBS and 
treated with ice-cold methanol/acetone (1:1) for 4 minutes followed by a wash in 
PBS. Cells on coverslips were incubated with primary antibodies (a polyclonal rabbit 
anti-pKi-67 antibody diluted 1:150, DAKO, Denmark); a polyclonal goat anti-lamin 
A antibody, diluted 1:100, Santa Cruz, USA) for 1 hour at room temperature, washed 
in PBS then incubated for 1 hour at room temperature with appropriate flurochrome-
conjugated secondary antibody. Cells were then washed three times with PBS and 
once with water then mounted onto glass slides in 30% (v/v) glycerol containing 12% 
(w/v) Mowiol (Aldrich, UK), 1 mg ml-1 DAPI and 2.5% (w/v) 1,4-diazobicyclo-
[2.2.2]-octane (DABCO; Sigma, UK).  
 
2.3 Apoptosis assay 
 
Adherent cells were harvested by trypsinization, collected by centrifugation, washed 
and finally resuspended in binding buffer (10mM HEPES/NaOH, pH 7.5, containing 
140mM NaCl and 2.5mM CaCl2) at a concentration of 106 cells ml-1. The cell 
suspension was incubated with 0.5µg ml-1 Annexin V FITC conjugate (Sigma, UK) 
and 2µg ml-1 propidium iodide solution (Sigma, UK) for 10 minutes in the absence of 
light. Fluorescence was determined by flow cytometry using a Beckman Coulter 
Epics XL.MCL, with the counter set at 10,000 events. 
3. Results. 
3.1 Replicative lifespans of HGPS fibroblasts. 
Since cellular aging is thought to contribute to organismal aging (Campisi, 
1998; Faragher and Kipling, 1998) we compared the growth of 3 normal and 7 HGPS 
dermal fibroblasts throughout their reproductive lifespans (Table 1. A). In agreement 
with previous studies (Martin et al., 1970) we observed a wide range of growth 
potentials of HGPS fibroblasts (mean population doublings = 27.1 ± 18.5 s.d., n=7) 
compared with normal fibroblasts (mean population doublings = 58 ± 6.2 s.d., n=3). 
Thus, whilst some cultures of HGPS fibroblasts failed to thrive, others performed 
almost as well as normal cultures. The limited reproductive lifespan of normal 
fibroblasts is characterised by a steady decline in the fraction of proliferating cells 
throughout their reproductive lifespan (Kill et al., 1994). Accordingly, as normal 
cultures age, the fraction of reproductively-sterile senescent cells increases. 
Interestingly, the rate of accumulation of senescent fibroblasts in cultures derived 
from another progeroid syndrome, Werner Syndrome (WS) is accelerated by up to 6-
fold (Kill et al., 1994). Therefore we wished to know how the rate of loss of 
proliferating cells within HGPS cultures compared with that of normal fibroblasts. At 
each passage fibroblasts grown on coverslips were fixed and stained for the presence 
of the Ki67 antigen (pKi67). Ki67 antibodies react with a nucleolar antigen that is 
present in proliferating cells only and thus provides a marker for the estimation of 
growth fraction (Kill, 1996). This fraction was plotted against the number of 
accumulated population doublings (APD) achieved by each culture. Thus, APD is a 
measure of growth whilst the percentage of Ki-67 positive cells represents the fraction 
of cells contributing to that growth. In each HGPS case tested we found that the 
fraction of proliferating cells was maintained at relatively high levels compared with 
normal cultures at the same APD level. However, the duration of this period of 
sustained growth varied according to the maximum reproductive lifespan (Fig. 1, A-
D). A striking difference between the growth of normal and HGPS fibroblasts is the 
rapid decline in proliferating cells observed towards the end of the HGPS culture’s 
lifespan. This is in marked contrast to the growth of normal fibroblasts that shows no 
such rapid loss towards the end of the reproductive lifespan but rather a smooth 
decline of proliferative cells throughout.  This can be seen clearly in Fig 1.E where 
the rates of cellular aging for two long-lived strains of HGPS fibroblasts and two 
normal fibroblast strains are plotted together. In this graph it is clear that young to late 
middle-aged HGPS cultures contain a relatively high fraction of proliferating cells 
compared with normal cultures. Subsequently, late passage HGPS experience a sharp 
decline in the fraction of proliferating cells and the values fall below those of normal 
cultures at an equivalent number of accumulated population doublings. Thus cellular 
aging in cultures of HGPS fibroblasts is characterised by an initial period of 
hyperproliferation followed by later rapid loss of proliferating cells. 
Hyperproliferation in HGPS fibroblasts is not likely to be caused by autocrine 
stimulation since these cells are serum-responsive and enter quiescence upon serum 
starvation (data not shown). 
3.2 Apoptosis in HGPS fibroblasts 
 To investigate the possible cause of the rapid loss of proliferating cells from 
HGPS cultures we compared levels of apoptosis in young and old HGPS and normal 
fibroblast cultures (Table 1, B). There is only a small increase in the fraction of 
apoptotic cells during aging of normal fibroblasts, which is in agreement with 
previous studies on adherent fibroblasts (DeJesus et al., 2002). However, in early 
passage cultures of HGPS fibroblasts the fractions of apoptotic cells are as high 
(2.2%) or higher (4.1%) than senescent, unaffected fibroblasts (2.2%). Within late 
passage HGPS cultures the fraction of apoptotic cells has risen dramatically to 16-
17%. Thus there is a clear 4-8-fold increase in the rate of apoptosis during cellular 
aging of HGPS fibroblasts that is not observed with normal fibroblasts. This finding is 
in broad agreement with a report of increased rates of apoptosis in cultures of cells 
derived from a HGPS model mouse (Mounkes et al., 2003).  
3.3 Changes in nuclear morphology during cellular aging of HGPS fibroblasts 
Previous reports have noted the presence of abnormal nuclear morphology 
within HGPS cultures (De Sandre-Giovannoli et al., 2003; Eriksson et al., 2003). 
However, we have noted that cellular aging within normal fibroblast cultures is 
characterised by an increase in the fraction of morphologically abnormal nuclei (Kill, 
I.R., unpublished data). Therefore, we wished to know whether the occurrence of 
abnormal nuclei in HGPS is linked to cellular aging or persists at a constant fraction 
throughout the reproductive lifespan. We scored the fractions of abnormal nuclei 
present in young and aged cultures of normal and HGPS fibroblasts (Fig. 2, Table 1. 
C). Abnormal nuclei are characterised by their deviation from a typical ellipsoid 
shape, displaying herniations, blebs and micronuclei. Within normal cultures the 
fraction of these nuclei rose from 5 to 32% from early to late passage. The occurrence 
of abnormal nuclei in cells of HGPS cultures was highly variable. However in each 
HGPS case tested we found there to be an increase in the fraction of abnormal nuclei 
with increasing cellular age. Thus within aged HGPS cultures the mean percentage of 
abnormal nuclei is 57.5 ±19.6 (SD, n=6) with a minimum value of 29.5% and a 
maximum value of 87.1%.  These data suggest that the generation of aberrant nuclear 
morphology seen in HGPS cells is as a result of cell division. 
3.4 Changes in nuclear lamina organisation and composition during cellular aging of 
HGPS fibroblasts 
 Finally, we wanted to assess the consequences of having mutations in the 
lamin A gene upon lamina organisation. Early and late passage HGPS fibroblasts 
were grown on coverslips then fixed and stained for the presence of lamin A using a 
lamin A–specific antibody. After staining, cells were classified according to their 
presentation of lamin A-containing structures (Fig. 3). Essentially all interphase cells 
produced a positive stain using an antibody that cannot distinguish lamin A and C 
regardless of age, indicating the presence of lamin C throughout HGPS cells’ 
lifespans (data not shown). In young HGPS cultures between 80 – 90% of nuclei 
showed typical nuclear rim staining (Fig 3, A). Another 7-14% showed rim staining 
but additionally showed speckles within the nuclear interior (Fig 3, B). Between 3-4% 
of young HGPS cells were negative for lamin A staining.  In contrast, typical nuclear 
rim staining in aged HGPS cultures had decreased to 33% and the proportion of nuclei 
showing rim and speckles staining had risen to about 26%. Furthermore, between 12-
22% of nuclei now displayed speckled lamin A staining in the absence of nuclear rim 
staining (fig 3, C) and between 17-29% showed no lamin A staining at all (Fig 3, D). 
Thus as HGPS fibroblasts age there is a loss of typical nuclear rim staining of lamin A 
structures and a concomitant increase in both intranuclear lamin A speckles and lamin 
A negative nuclei.  
4. Discussion. 
From these studies we are beginning to gain a picture of the possible processes 
leading to premature aging of HGPS individuals. Our data support the idea that a 
HGPS cellular phenotype develops progressively from what appear to be essentially 
normal cells to cells that possess an abnormal lamina, abnormal nuclear morphology 
and are prone to apoptosis. A link between lamin A and apoptosis is clearly 
established (Rao et al., 1996), although lamin A cleavage seems to be a consequence 
rather than a cause of apoptosis. However, cleavage of only a small fraction of A-type 
lamins is sufficient to cause disintegration of the lamina (Broers et al., 2002). This 
finding may be highly relevant to our understanding of the cause of apoptosis in 
HGPS cells in which lamin A mutations may generate dominant-negative forms of 
lamin A. 
Our finding that young HGPS cultures contain higher fractions of proliferating 
cells compared with young normal cultures suggests that proliferative control is 
deregulated. This process could be mediated by growth regulators known to interact 
with lamin-containing structures such as pRb (Markiewicz et al., 2002; Ozaki et al., 
1994). Alternatively, since there is a strong link between genome organisation and 
structures at the nuclear envelope (Bridger and Bickmore, 1998; Holaska et al., 2002) 
then a compromised lamina organisation may result in aberrant gene expression 
leading to deregulated growth. In either case it is likely that a disorganised lamina is 
less able to protect the genome from physical trauma particularly encountered during 
the upheavals of mitosis and nuclear reassembly. Thus with increasing rounds of cell 
division there is an increasing likelihood that the resultant daughter nuclei will 
develop abnormally. In some cases the abnormality will lead to apoptosis. 
Superimposed on these processes is that of cellular senescence. Therefore with each 
successive round of cell division HGPS fibroblasts have an increasing probability of 
either entering senescence or proceeding to apoptosis. If apoptosis in HGPS cultures 
is driven by cell division then senescent HGPS fibroblasts will be refractory to 
apoptosis since they are unable to divide. This idea is further supported by the finding 
that telomere lengths are reduced in HGPS fibroblasts (Allsopp et al., 1992). Thus, 
proliferating HGPS fibroblasts, presumably with long telomeres, are prone to 
apoptosis whilst senescent HGPS fibroblasts, presumably with short telomeres are 
resistant and accumulate within the cultures. 
It is highly likely that accumulation of senescent cells within tissues with 
increasing age contributes to age-dependent decline in tissue function (Campisi, 1998; 
Faragher and Kipling, 1998). Thus, we propose that in HGPS individuals, mutations 
in the lamin A gene results in deregulation of growth control, hyperproliferation and 
increased rates of apoptosis. As a consequence there is premature loss of functional 
“young” cells and a concomitant premature accumulation of senescent cells, both of 
which promote the age-related decline in tissue function leading to premature 
senescence of the individual. Indeed, post-mortem studies have shown that progeric 
arteries are depleted of smooth muscle cells, which is consistent with atherosclerotic 
disease (Stehbens et al., 2001).  
Interestingly, the rates of cellular aging in cultures of fibroblasts derived from 
another progeroid syndrome, Werner Syndrome are accelerated by up to 6-fold 
(Faragher et al., 1993; Kill et al., 1994). Thus, cellular aging of WS fibroblasts is 
characterised by premature accumulation of senescent cells whilst HGPS is 
characterised by premature loss of proliferating cells through apoptosis generating a 
culture also rich in senescent cells. Although mutations in the WRN helicase gene 
accounts for 80% of WS cases, it has recently been shown that 3% (4 out of 129 
cases) are due to mutations in LMNA (Chen et al., 2003). Clinically, there is little 
overlap between WS and HGPS (Martin and Oshima, 2000). However, at the cellular 
level both syndromes seem to originate from genomic instability and both lead to 
accelerated aging of certain tissues. There is no strong evidence to suggest that either 
HGPS or WS are characterised by premature aging of the brain or central nervous 
system. Since most of this tissue is post-mitotic then this is entirely consistent with 
the view that cell turnover and tissue homeostasis are important factors in the aging of  
certain tissues only. Indeed, in both HGPS and WS it is only those tissues undergoing 
turnover that are affected. Therefore, this provides powerful evidence that loss of 
normal cellular function, either through apoptosis or senescence, or a combination of 
both, leads to the decline in tissue-specific function characteristic of normal aging and 
which occurs prematurely in the human progeroid syndromes. 
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Table 1. Comparison of normal and HGPS fibroblasts. 
A.  Maximum growth potential of normal and HGPS fibroblast cultures. 
 
Cell Strain Mutation Max 
APD 
Slope Y-intercept R2 Standard 
error 
AG10677 E145K* 6.3 nd nd nd nd 
AG03199 ? 11.7 nd nd nd nd 
AG10750 ? 13.8 nd nd nd nd 
AG10578 Not G608G+ 18.9 nd nd nd nd 
AG06297 G608G* 44.3 nd nd nd nd 
AG08466 Not G608G+ 45.5 -2.1 114 0.8350 12.41 
AG11572 ? 49.5 -1.5 95 0.6903 16.01 
1Br WT 65.0 -0.9 60 0.8007 5.86 
2DD WT 53 -0.9 56 0.7294 8.33 
NB1 WT 56 -1.2 68 0.7892 7.22 
 
B. Apoptosis. 
 
Cell Strain Early passage 
(% replicative lifespan 
completed) 
Late passage 
 (% replicative lifespan 
completed) 
2DD 0.02 (14.4) 2.2 (95.0) 
AG08466 2.2 (18.9) 16.2 (99.6) 
AG11572 4.1 (17.2) 17.1 (97.8) 
 
 
C. Percentages of abnormal nuclei. 
 
Cell Strain Early passage 
(% replicative lifespan 
completed) 
Late passage 
 (% replicative lifespan 
completed) 
2DD 5.5 ± 0.1 (14.4) 32.1 ± 4.5 (95) 
NB1 2.3 ± 0.8 (7.6) 17.9 ± 2.0 (96.2) 
AG08466 8.5 ± 1.8 (18.9) 48.9 ± 1.5 (99.6) 
AG11572 4.8 ± 0.5 (17.2) 52.6 ± 1.3 (97.8) 
AG10578 14.1 ± 1.4 (38.6) 29.5 ± 0.3 (93.0) 
AG06297 29.2 ± 2.1 (78.8) 70.3 ± 4.2 (96.9) 
AG03199 n.d. 56.6 ± 2.2 (99.5) 
AG10677 n.d. 87.1 ± 2.2 (99.5) 
 
Growth potential determined by calculating the maximum number of population 
doublings (Max APD) and includes information supplied by the Coriell Cell 
Repository for HGPS fibroblast strains AG10677, AG03199, AG10750, AG10578, 
AG06297, AG08466 and AG11572. 1BR, 2DD and NB1 are all normal fibroblast 
strains. Mutation data is included where known. * indicates previously reported 
mutation analyses (Eriksson et al., 2003). + indicates data from Dr. N. Levy, personal 
communication. WT = wild type. Regression lines were fitted where appropriate. 
Slope values are %Ki-67 positive nuclei APD-1 , R2 = correlation coefficient, nd = not 
done. Standard error of the regression line provides a measure of “goodness of fit”.
 Figure 1. Cellular aging of normal and Hutchinson-Gilford progeria fibroblasts. 
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Rates of cellular aging were assessed by estimating the percentage of proliferating 
cells remaining within fibroblasts cultures at increasing population doubling levels.
Proliferating cells were identified by positive staining with Ki-67 antibodies. A) 
HGPS strain AG08466, B)  HGPS strain AG11572, C) HGPS strain AG10578, D
HGPS strain AG06297. Early passage cells were not available for AG06297. E) 
shows a comparison between two normal fibroblasts cultures (1BR and 2DD) and
HGPS fibroblast cultures (AG08466 and AG11572). Regression lines were fitted 
using the method of least squares. Details of the graphs are shown in Table 1. 
  
igure 2. Abnormal nuclear morpholgy in cultures of HGPS fibroblasts. HGPS 
fibroblasts were grown on glass coverslips, fixed and stained with DAPI to reveal 
es 
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DNA. Representative images show a normal control nucleus (A) and the range of 
abnormal nuclear morphologies observed in HGPS cultures (B-F). Abnormalities 
could be minor such as herniations in the nuclear periphery (B) or folds and crevic
(C). Abnormalites can be more severe such as fragments (D) and lobules (E). Pane
shows a striking fragmentation of the nucleus to generate micronuclei (note the 
change in scale). Scale bars = 10 µm. 
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ure 3. Analysis of lamin A staining in Hutchison-Gilford Progeria Syndrome 
. (A) Cultures of HGPS fibroblasts were grown on coverslips, fixed and 
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stained for the presence of lamin A and DAPI to reveal DNA. The panels show 
representative images of lamin A staining classified according to pattern. Scale bars =
10µm. (B) Percentages of  HGPS fibroblasts presenting each staining pattern in youn
(Y) and senescent (O) HGPS strains AG08466 and AG11572. 
 
 
